Tab. 2:
Cell types used in these studies
| Organ/Tissue | Origin | Cell type name | Number of phenotypes | QC “Pass” phenotypes | QC “Fail” phenotypes |
|---|---|---|---|---|---|
| Skin | Malignant melanoma | A375 | 3 | 2 | 1 |
| Lung | Epithelial carcinoma | A549 | 3 | 0 | 3 |
| Liver | Cholangiosarcoma | HEPARG | 3 | 1 | 2 |
| Liver | Hepatocellular carcinoma | HEPG2 | 3 | 2 | 1 |
| Lung | Microvascular endothelial cells | HLMVEC | 4 | 2 | 2 |
| Gut | Colorectal adenocarcinoma | HT29 | 4 | 0 | 4 |
| Brain | Glioblastoma | LN229 | 4 | 2 | 2 |
| Breast | Epithelial adenocarcinoma | MCF7 | 3 | 2 | 1 |
| Bone marrow | Neuroblastoma | SH-SY5Y | 4 | 2 | 2 |
| Heart | iPSC-derived cardiomyocytes | CM | 14 | 12 | 2 |
| Liver | iPSC-derived hepatocytes | HEP | 6 | 4 | 2 |
| Blood vessel | iPSC-derived endothelial cells | ENDO | 9 | 4 | 5 |
| Blood vessel | Umbilical cord endothelial cells | HUVEC | 6 | 5 | 1 |
| Brain | iPSC-derived neuronal cells | NEUR | 4 | 4 | 0 |
| Blood | iPSC-derived macrophages | MACRO | 1 | 0 | 1 |
| 71 | 42 | 29 | |||